PolyCore Therapeutics
VerifiedPolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$1—2m (Dealroom.co estimates Jun 2016.)
Philadelphia Pennsylvania (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $4.7m | Early VC | |
| Total Funding | 000k | ||
Related Content
Recent News about PolyCore Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.